1-13 of 13
Stefan Faderl, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Young Adults with Acute Lymphoblastic Leukemia (ALL) Treated with Adapted Augmented Berlin-Frankfurt-Munster (ABFM) Therapy

Michael Rytting, M.D., Deborah Thomas, M.D., Anna Franklin, M.D., William Wierda, M.D., Stefan Faderl, M.D., Farhad Ravandi, M.D., Brenda Muriera, RN, Hagop M. Kantarjian, MD, Susan O’Brien, M.D.
Journal: Blood
Blood (2008) 112 (11): 3957.
https://doi.org/10.1182/blood.V112.11.3957.3957
Published: 2008
Journal Articles

Phase II Study of Dasatinib (SPRYCEL™) in Philadelphia Chromosome-Negative Acute and Chronic Myeloid Diseases, Including Systemic Mastocytosis.

Srdan Verstovsek, MD, PhD, Tefferi Ayalew, M.D., Cortes Jorge, M.D., Susan O’Brien, M.D., Guillermo Garcia-Manero, M.D., Animesh Pardanani, M.D., Cem Akin, M.D., Stefan Faderl, M.D., Deborah Thomas, M.D., Hagop Kantarjian, M.D.
Journal: Blood
Blood (2007) 110 (11): 3551.
https://doi.org/10.1182/blood.V110.11.3551.3551
Published: 2007
Journal Articles

Phase II Study of Lenalidomide and Prednisone for Patients with Myelofibrosis.

Alfonso Quintás-Cardama, MD, Ayalew Tefferi, M.D., Deborah Thomas, M.D., Jorge Cortes, M.D., Farhad Ravandi, M.D., Stefan Faderl, M.D., Guillermo Garcia-Manero, M.D., Gautam Borthakur, M.D., Neda Bell, M.D., Catriona Byrne, M.D., Hagop Kantarjian, M.D., Srdan Verstovsek, M.D., Ph.D
Journal: Blood
Blood (2007) 110 (11): 3545.
https://doi.org/10.1182/blood.V110.11.3545.3545
Published: 2007
Journal Articles

Survival Benefit with Decitabine Compared to Historical Experience with Intensive Chemotherapy in Patients with Higher Risk Myelodysplastic Syndrome (MDS).

Elias Jabbour, MD, Hagop M. Kantarjian, M.D., Jorge Cortes, M.D., William G. Wierda, M.D., Ph.D., Alessandra Ferrajoli, M.D., Stefan Faderl, M.D., Susan O’Brien, M.D., Farhad Ravandi-Kashani, M.D., Srdan Verstovsek, M.D., Ph.D., Guillermo Garcia-Manero, M.D., Jan Davisson, BS, ADN, Francis Giles, M.D., Jianqin Shan, Ph.D., Jean-Pierre Issa, M.D.
Journal: Blood
Blood (2006) 108 (11): 2652.
https://doi.org/10.1182/blood.V108.11.2652.2652
Published: 2006
Journal Articles

PEG-Intron Therapy in Patients with Philadelphia Chromosome-Negative Myeloproliferative Disorders (MPD): Final Result of a Phase II Study.

Elias Jabbour, MD, Hagop Kantarjian, M.D., Charles A. Koller, M.D., Stefan Faderl, M.D., Alessandra Ferrajoli, M.D., Mary Ann Richie, R.N., Guillermo Garcia-Manero, M.D., Jorge Cortes, M.D., Zeev Estrov, M.D., Farhad Ravandi-Kashani, M.D., Francis Giles, M.D., Srdan Verstovsek, M.D.
Journal: Blood
Blood (2006) 108 (11): 3636.
https://doi.org/10.1182/blood.V108.11.3636.3636
Published: 2006
Journal Articles

Intracranial Hemorrhage (ICH) in Patients (pts) with Newly Diagnosed Leukemia: Incidence and Effect on Outcome.

Yasuhiro Oki, M.D., Elias Jabbour, M.D., Hagop Kantarjian, M.D., Elihu Estey, M.D., Jorge E. Cortes, M.D., Stefan Faderl, M.D., Sherry Pierce, RN, BSN, BA, Xian Zhou, MS, BS, B. Nebiyou Bekele, Ph.D., Guillermo Garcia-Manero, M.D.
Journal: Blood
Blood (2004) 104 (11): 4530.
https://doi.org/10.1182/blood.V104.11.4530.4530
Published: 2004
Journal Articles

Survival Advantage for Patients (pts) with Chronic Myeloid Leukemia (CML) in Accelerated Phase (AP) Treated with Imatinib.

Jorge Cortes, M.D., Moshe Talpaz, M.D., Susan O’Brien, M.D., Guillermo Garcia-Manero, M.D., Farhad Ravandi-Kashami, M.D., Francis Giles, M.D., Stefan Faderl, M.D., William Wierda, M.D., Jianqin Shan, Ph.D., Mary Beth Rios, R.N., Hagop Kantarjian, M.D.
Journal: Blood
Blood (2004) 104 (11): 1006.
https://doi.org/10.1182/blood.V104.11.1006.1006
Published: 2004
Journal Articles

Phase I Study of Lonafarnib (SCH66336) in Combination with Imatinib for Patients (Pts) with Chronic Myeloid Leukemia (CML) after Failure to Imatinib.

Jorge Cortes, M.D., Susan O’Brien, M.D., Srdan Verstovsek, M.D., George Daley, M.D., Charles Koller, M.D., Alessandra Ferrajoli, M.D., Odeal Pate, R.N., Stefan Faderl, M.D., Farhad Ravandi-Kashani, M.D., Moshe Talpaz, M.D., Yali Zhu, Ph.D., Paul Statkevich, Ph.D., Mary Sugrue, M.D., Hagop Kantarjian, M.D.
Journal: Blood
Blood (2004) 104 (11): 1009.
https://doi.org/10.1182/blood.V104.11.1009.1009
Published: 2004
Journal Articles

A Phase I Study of Tipifarnib in Combination with Imatinib Mesylate (IM) for Patients (Pts) with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) Who Failed IM Therapy.

Jorge Cortes, M.D., Guillermo Garcia-Manero, M.D., Susan O’Brien, M.D., Ingrid Hernandez, R.N., Wayne Rackoff, M.D., Stefan Faderl, M.D., Deborah Thomas, M.D., Alessandra Ferrajoli, M.D., Moshe Talpaz, M.D., Hagop Kantarjian, M.D.
Journal: Blood
Blood (2004) 104 (11): 1011.
https://doi.org/10.1182/blood.V104.11.1011.1011
Published: 2004
Journal Articles

Is the Proposed World Health Organization (WHO) Classification for Chronic Myeloid Leukemia (CML) of Clinical Value in the Imatinib Era?.

Jorge Cortes, M.D., Susan O’Brien, M.D., Guillermo Garcia-Manero, M.D., Stefan Faderl, M.D., Jenny Shan, Ph.D., Francis Giles, M.D., Srdan Verstovsek, M.D., Mary Beth Rios, R.N., Moshe Talpaz, M.D., Hagop Kantarjian, M.D.
Journal: Blood
Blood (2004) 104 (11): 1014.
https://doi.org/10.1182/blood.V104.11.1014.1014
Published: 2004
Journal Articles

WP-1066, a Next-Generation Member of JAK-Stat Inhibitors, Induces Cell Cycle Arrest, Abrogates Proliferation, and Induces Apoptosis of Acute Myeloid Leukemia (AML) Cells.

Alessandra Ferrajoli, M.D., Stefan Faderl, M.D., Quin Van, B.S., David M. Harris, B.S., Waldemar Priebe, Ph.D., Hagop M. Kantarjian, M.D., Moshe Talpaz, M.D., Zeev Estrov, M.D.
Journal: Blood
Blood (2004) 104 (11): 1169.
https://doi.org/10.1182/blood.V104.11.1169.1169
Published: 2004
Journal Articles

Intravenous Voriconazole (IV-VORI) Prevents Invasive Fungal Infections (IFI) in Patients (pts) with Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS).

Gloria N. Mattiuzzi, M.D., Gladys Alvarado, M.D., Hagop M. Kantarjian, M.D., Srdan Verstovsek, M.D., Ph.D., Maria Cabanillas, M.D., Stefan Faderl, M.D., Joann T. Lim, PharmD, Francis Giles, M.D., Miloslav Beran, M.D., Ph.D, Susan O’Brien, M.D., Elihu H. Estey, M.D.
Journal: Blood
Blood (2004) 104 (11): 885.
https://doi.org/10.1182/blood.V104.11.885.885
Published: 2004
Journal Articles

PEG-Intron for Myeloproliferative Diseases: An Update of Ongoing Phase II Study.

Srdan Verstovsek, M.D., Ph.D., Kristie Lawhorn, BCLS, R.N., Francis Giles, M.D., Jorge Cortes, M.D., Deborah Thomas, M.D., Guillermo Garcia-Manero, M.D., Alessandra Ferrajoli, M.D., Stefan Faderl, M.D., Miloslav Beran, M.D., Ph.D., Moshe Talpaz, M.D., Hagop Kantarjian, M.D.
Journal: Blood
Blood (2004) 104 (11): 1517.
https://doi.org/10.1182/blood.V104.11.1517.1517
Published: 2004